<DOC>
	<DOCNO>NCT01043302</DOCNO>
	<brief_summary>The purpose study determine whether whether surgical resection follow chemotherapy superior systemic chemotherapy alone term treatment outcome quality life ( QOL ) patient primary intestinal lymphoma .</brief_summary>
	<brief_title>Multicenter Cross Sectional Study Primary Intestine Lymphoma</brief_title>
	<detailed_description>Intestine one commonly involved extranodal sit non-Hodgkin 's lymphoma ( NHL ) . Thus , small large Intestine account approximately 30-40 % primary gastrointestinal tract lymphoma . More 70 % intestinal lymphoma present localized disease , surgery bowel resection perform many patient intestinal lymphoma diagnosis treatment . However , still unclear whether surgical resection follow chemotherapy superior systemic chemotherapy alone term treatment outcome quality life ( QOL ) . Thus , analyze clinical feature treatment outcome patient NHL intestine , time perform multicenter cross-sectional study QOL survivor intestine NHL . We evaluate treatment outcome patient intestine NHL hospital affiliate Consortium Improving Survival Lymphoma ( CISL ) Korea . We assess QOL survivor complete treatment use EORTC QLQ-C30 questionnaire .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Primary intestine lymphoma . Definition primary intestine lymphoma : 1 . Dominant site small large intestine without regional lymph node involvement 2 . Distant lymph node involvement allow intestine lesion present site 3 . Contiguous involvement organ liver , spleen allow Intestine involvement dissemination process stage IV nodal lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>lymphoma , intestine , outcome , quality life</keyword>
</DOC>